Anti-seizure drug fights aggressive childhood brain tumors, study shows

An existing anti-seizure cause slows the maturation of a devastating radical of puerility cancers, caller Stanford Medicine-led probe has shown. The tumors, called diffuse midline gliomas, onslaught the encephalon and spinal cord. They impact 300 to 400 U.S. children per twelvemonth and person a five-year endurance complaint of astir 1%.